These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV. Mallory MA; Hymas WC; Simmon KE; Pyne MT; Stevenson JB; Barker AP; Hillyard DR; Hanson KE J Clin Microbiol; 2023 Dec; 61(12):e0082923. PubMed ID: 38092673 [TBL] [Abstract][Full Text] [Related]
4. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing. López-Aladid R; Guiu A; Mosquera MM; López-Medrano F; Cofán F; Linares L; Torre-Cisneros J; Vidal E; Moreno A; Aguado JM; Cordero E; Martin-Gandul C; Carratalá J; Sabé N; Niubó J; Cervera C; Capón A; Cervilla A; Santos M; Bodro M; Muñoz P; Fariñas MC; Antón A; Aranzamendi M; Montejo M; Pérez-Romero P; Len O; Marcos MÁ PLoS One; 2019; 14(7):e0219701. PubMed ID: 31318908 [TBL] [Abstract][Full Text] [Related]
5. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients. Garrigue I; Moulinas R; Recordon-Pinson P; Delacour ML; Essig M; Kaminski H; Rerolle JP; Merville P; Fleury H; Alain S J Clin Virol; 2016 Jul; 80():74-81. PubMed ID: 27214758 [TBL] [Abstract][Full Text] [Related]
6. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients. Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537 [TBL] [Abstract][Full Text] [Related]
7. Clinical next-generation sequencing assay combining full-length gene amplification and shotgun sequencing for the detection of CMV drug resistance mutations. von Bredow B; Caldera JR; Cerón S; Chan JL; Gray HK; Garner OB; Yang S J Clin Virol; 2023 Aug; 165():105520. PubMed ID: 37336174 [TBL] [Abstract][Full Text] [Related]
8. Detection of cytomegalovirus drug resistance mutations by next-generation sequencing. Sahoo MK; Lefterova MI; Yamamoto F; Waggoner JJ; Chou S; Holmes SP; Anderson MW; Pinsky BA J Clin Microbiol; 2013 Nov; 51(11):3700-10. PubMed ID: 23985916 [TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan. Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing. Guermouche H; Burrel S; Mercier-Darty M; Kofman T; Rogier O; Pawlotsky JM; Boutolleau D; Rodriguez C Antiviral Res; 2020 Jan; 173():104647. PubMed ID: 31706899 [TBL] [Abstract][Full Text] [Related]
11. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study. Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982 [TBL] [Abstract][Full Text] [Related]